KLF9 and neoplasm: Conversely, tumor suppressors such as miR-378h, miR-125b-5p, and KLF9 were shown to inhibit KIAA1522 expression, highlighting its potential as a central therapeutic target across diverse malignancies (Guo et al., 2024; Lee et al., 2023; Li et al., 2018).